Hikma CEO takes the fall for cutting guidance
HIKMA PHARMACEUTICALS (HIK) – Healthcare Price: £14.95 -1.4% P/E: 10.5x Market Cap: £4.45bn Yield: 4% A month after the firm lowered its outlook, Hikma chief executive Riad Mishlawi is out the door and chairman Said Darwazah is stepping back in while the company looks for a new candidate. Group guidance remains unchanged from the 6 … Continue reading Hikma CEO takes the fall for cutting guidance
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed